A multicentre, retrospective study in patients with multiple sclerosis treated with natalizumab in real-world setting in Japa
Not Applicable
Recruiting
- Conditions
- Multiple sclerosis (MS)
- Registration Number
- JPRN-UMIN000044955
- Lead Sponsor
- Tohoku Medical and Pharmaceutical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are deemed inappropriate for participation in this study by the principal investigator or sub-investigator.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method